Wiernik PH - Search Results

1

Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study.

Parkinson DR, Abrams JS, Wiernik PH, Rayner AA, Margolin KA, Van Echo DA, Sznol M, Dutcher JP, Aronson FR, Doroshow JH, et al. Parkinson DR, et al. Among authors: wiernik ph. J Clin Oncol. 1990 Oct;8(10):1650-6. doi: 10.1200/JCO.1990.8.10.1650. J Clin Oncol. 1990. PMID: 2213101 Clinical Trial.

2

High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinoma.

Abrams JS, Rayner AA, Wiernik PH, Parkinson DR, Eisenberger M, Aronson FR, Gucalp R, Atkins MB, Hawkins MJ. Abrams JS, et al. Among authors: wiernik ph. J Natl Cancer Inst. 1990 Jul 18;82(14):1202-6. doi: 10.1093/jnci/82.14.1202. J Natl Cancer Inst. 1990. PMID: 2194036 Clinical Trial.

3

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.

Wiernik PH, Schwartz EL, Einzig A, Strauman JJ, Lipton RB, Dutcher JP. Wiernik PH, et al. J Clin Oncol. 1987 Aug;5(8):1232-9. doi: 10.1200/JCO.1987.5.8.1232. J Clin Oncol. 1987. PMID: 2887641

4

Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial.

Fisher RI, Coltman CA Jr, Doroshow JH, Rayner AA, Hawkins MJ, Mier JW, Wiernik P, McMannis JD, Weiss GR, Margolin KA, et al. Fisher RI, et al. Ann Intern Med. 1988 Apr;108(4):518-23. doi: 10.7326/0003-4819-108-4-518. Ann Intern Med. 1988. PMID: 3258138

5

Metastatic melanoma: is biochemotherapy the future?

Alexandrescu DT, Dutcher JP, Wiernik PH. Alexandrescu DT, et al. Among authors: wiernik ph. Med Oncol. 2005;22(2):101-11. doi: 10.1385/mo:22:2:101. Med Oncol. 2005. PMID: 15965272 Review.

6

Interleukin-2 Can Cure Kidney Cancer.

Dutcher JP, Wiernik PH. Dutcher JP, et al. Among authors: wiernik ph. Oncologist. 2018 Sep;23(9):e107. doi: 10.1634/theoncologist.2018-0038. Epub 2018 Aug 13. Oncologist. 2018. PMID: 30104291 Free PMC article.

7

Hypersensitivity reactions from taxol.

Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, Baker JR Jr, Van Echo DA, Von Hoff DD, Leyland-Jones B. Weiss RB, et al. Among authors: wiernik ph. J Clin Oncol. 1990 Jul;8(7):1263-8. doi: 10.1200/JCO.1990.8.7.1263. J Clin Oncol. 1990. PMID: 1972736

8

Successful treatment of hair cell leukemia with 2'-deoxycoformycin after failure of interferons alpha or beta.

Dutcher JP, Salva KM, Wiernik PH. Dutcher JP, et al. Among authors: wiernik ph. Am J Clin Oncol. 1990 Aug;13(4):290-3. doi: 10.1097/00000421-199008000-00004. Am J Clin Oncol. 1990. PMID: 2198792 Review.

9

Acute renal dysfunction during interleukin-2 treatment: suggestion of an intrinsic renal lesion.

Shalmi CL, Dutcher JP, Feinfeld DA, Chun KJ, Saleemi KR, Freeman LM, Lynn RI, Wiernik PH. Shalmi CL, et al. Among authors: wiernik ph. J Clin Oncol. 1990 Nov;8(11):1839-46. doi: 10.1200/JCO.1990.8.11.1839. J Clin Oncol. 1990. PMID: 2230870

10

Evaluation of natural killer and lymphokine-activated killer (LAK) cell activity in vivo in patients treated with high-dose interleukin-2 and adoptive transfer of autologous LAK cells.

Walewski J, Paietta E, Dutcher J, Wiernik PH. Walewski J, et al. Among authors: wiernik ph. J Cancer Res Clin Oncol. 1989;115(2):170-4. doi: 10.1007/BF00397919. J Cancer Res Clin Oncol. 1989. PMID: 2654134 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

769 results

Search Page

Filters